SCHEMBL6085176

SCHEMBL6085176

CS(=O)(=O)Nc1cccc(-c2n[nH]cc2-c2nc3cc(-c4ccccc4)ccc3o2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 1/20 0.46
PTPN1 P18031 12/20 0.45
PTPN5 P54829 11/20 0.45
PTPN2 P17706 10/20 0.45
MEN1 O00255 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
HSPD1 P10809 2/20 0.44
HSPE1 P61604 2/20 0.44
LMNA P02545 2/20 0.44
USP2 O75604 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086978 0.90 ALDH1A1 (0.49) PTPN1PTPN5PTPN2MEN1KMT2A
SCHEMBL6086906 0.90 PTPN1 (0.60) PTPN1PTPN5PTPN2MEN1CYP1A2
SCHEMBL6084084 0.85 ALDH1A1 (0.52) PTPN1PTPN5PTPN2MEN1CYP1A2
SCHEMBL6084550 0.83 AGPAT2 (0.54) AGPAT2MEN1KMT2AALDH1A1KDM4E
SCHEMBL6085198 0.82 PTPN1 (0.61) PTPN1PTPN5PTPN2MEN1CYP1A2
SCHEMBL6086019 0.81 HPGD (0.51) PTPN1PTPN5PTPN2KMT2AALDH1A1
SCHEMBL6087192 0.81 PTPN5 (0.52) PTPN1PTPN5PTPN2MEN1KMT2A
SCHEMBL6200297 0.80 PTPN1 (0.63) PTPN1PTPN5PTPN2MEN1CYP1A2
SCHEMBL6085294 0.80 PTPN2 (0.56) PTPN1PTPN5PTPN2KMT2AALDH1A1
SCHEMBL6084830 0.80 AGPAT2 (0.53) AGPAT2MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US claimed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US claimed
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US disclosed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP disclosed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors MAP3K15, MAP3K20, MAP3K3 AGPAT2 3284/4885PTPN1 344/4885PTPN5 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.